# Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

> **NCT06250543** · PHASE4 · COMPLETED · sponsor: **Niko Kavcic** · enrollment: 64 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** AbobotulinumtoxinA 300 UNT
- **DRUG:** IncobotulinumtoxinA 100 UNT
- **DRUG:** Lidocain
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT06250543
- **Lead sponsor:** Niko Kavcic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-14
- **Primary completion:** 2022-11-25
- **Final completion:** 2022-11-25
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06250543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06250543, "Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT06250543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*